FOLD logo

Amicus Therapeutics, Inc. (FOLD)

Profile

Full Name

Amicus Therapeutics, Inc.

Ticker

NASDAQ: FOLD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 31, 2007

Indexes

Not included

Website

https://amicusrx.com

Employees

499

Key Details

Price

$7.95(-0.75%)

Market cap

$2.45B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$528.29M(+32.29% YoY)

Annual EPS

-$0.18(+64.71% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.95
    FOLD price is $7.95

    30-Day Relative Volume

    1.04
    FOLD 30-day relative volume is 1.04

    Price Performance

    Price Today change

    -0.75%
    FOLD price is down -0.75% today

    Price YTD change

    -15.61%
    FOLD price is down -15.61% since January 1st

    Price 1-year change

    -29.02%
    FOLD price is down -29.02% year-on-year

    Price 3-year change

    -25.14%
    FOLD price is down -25.14% over the past 3 years

    Price Range

    Price All-time high

    $25.39
    FOLD price is currently -68.69% below its historical high of $25.39

    Price 3-year low

    $5.51
    FOLD price is currently +44.28% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.45B
    FOLD market capitalization is $2.45 billion

    Market cap 3-year change

    -17.74%
    FOLD market capitalization is down -17.74% over the past 3 years

    Market cap All-time high

    $6.49B
    FOLD market capitalization is currently -62.22% below its historical high of $6.49 billion

    Market cap sector rank

    82.89%
    FOLD market capitalization is higher than 82.89% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.93%
    FOLD shares outstanding is up +3.93% year-on-year

    Shares Outstanding 3-Year Change

    +9.89%
    FOLD shares outstanding is up +9.89% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    FOLD beta is 0.66

    200-day SMA

    $7.82
    FOLD price is currently +1.67% above its 200-day simple moving average

    50-day SMA

    $6.99
    FOLD price is currently +13.80% above its 50-day simple moving average

    RSI

    64.38
    FOLD 14-day relative strength index is 64.38

    Volume

    1.04
    FOLD 30-day relative volume is 1.04

    ATR

    $0.28
    FOLD average true range is $0.28

    10-day Historical Volatility

    29.55%
    FOLD 10-day historical volatility is 29.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $528.29M
    FOLD annual revenue is $528.29 million

    Revenue Analysts estimate

    $626.60M
    FOLD annual revenue is currently -15.69% lower than the consensus analysts' forecast

    Revenue 1-year change

    +32.29%
    FOLD annual revenue is up +32.29% year-on-year

    Revenue Sector rank

    81.53%
    FOLD annual revenue is higher than 81.53% of companies in Healthcare sector

    EPS

    EPS

    -$0.18
    FOLD annual earnings per share is -$0.18

    EPS Analysts estimate

    $0.32
    FOLD annual earnings per share is currently -155.62% lower than the consensus analysts' forecast

    EPS 1-year change

    +64.71%
    FOLD annual earnings per share is up +64.71% year-on-year

    EPS Sector rank

    70.95%
    FOLD annual earnings per share is higher than 70.95% of companies in Healthcare sector

    Profit

    Gross profit

    $466.81M
    FOLD annual gross profit is $466.81 million

    Gross margin

    88.36%
    FOLD annual gross profit margin is 88.36%

    Operating profit

    $34.06M
    FOLD annual operating income is $34.06 million

    Operating margin

    6.45%
    FOLD annual operating profit margin is 6.45%

    Net income

    -$56.11M
    FOLD annual net profit is -$56.11 million

    Net margin

    -10.62%
    FOLD annual net profit margin is -10.62%

    Expenses

    Total expenses

    $584.40M
    FOLD annual total expenses is $584.40 million

    Operating expenses

    $432.74M
    FOLD annual total operating expenses is $432.74 million

    Cost of goods sold

    $61.49M
    FOLD annual cost of goods sold is $61.49 million

    Selling, general & administrative expenses

    $0.00
    FOLD annual SGA is $0.00

    Depreciation and amortization

    $8.55M
    FOLD annual depreciation & amortization is $8.55 million

    Interest expense

    $0.00
    FOLD annual interest expense is $0.00

    Income tax

    $27.35M
    FOLD annual income tax is $27.35 million

    EBIT & EBITDA

    EBIT

    $20.84M
    FOLD annual earnings before interest & taxes is $20.84 million

    EBITDA

    $42.61M
    FOLD annual EBITDA is $42.61 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $785.03M
    FOLD annual total assets is $785.03 million

    Non current assets

    $280.30M
    FOLD annual long term assets is $280.30 million

    Current assets

    $504.74M
    FOLD annual total current assets is $504.74 million

    Cash and cash equivalents

    $249.95M
    FOLD annual cash & cash equivalents is $249.95 million

    Accounts receivable

    $101.10M
    FOLD annual accounts receivable is $101.10 million

    Inventory

    $118.78M
    FOLD annual inventory is $118.78 million

    Liabilities

    Total liabilities

    $590.99M
    FOLD annual total liabilities is $590.99 million

    Long term liabilities

    $442.29M
    FOLD annual total long term liabilities is $442.29 million

    Current liabilities

    $148.70M
    FOLD annual total current liabilities is $148.70 million

    Accounts payable

    $12.95M
    FOLD annual accounts payable is $12.95 million

    Debt

    Total debt

    $443.64M
    FOLD annual total debt is $443.64 million

    Total debt 1-year change

    -0.32%
    FOLD annual total debt is down -0.32% year-on-year

    Long term debt

    $435.19M
    FOLD annual long term debt is $435.19 million

    Short term debt

    $8.46M
    FOLD annual short term debt is $8.46 million

    Equity & Capital

    Shareholders equity

    $194.04M
    FOLD annual stockholders equity is $194.04 million

    Book value

    $194.05M
    FOLD annual book value is $194.05 million

    Retained earnings

    -$2.74B
    FOLD annual retained earnings is -$2.74 billion

    Working capital

    $356.03M
    FOLD annual working capital is $356.03 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$33.89M
    FOLD annual cash flow from operations is -$33.89 million

    Cash from operations 1-year change

    +50.95%
    FOLD annual cash flow from operations is up +50.95% year-on-year

    Cash from investing

    -$560.00K
    FOLD annual cash flow from investing activities is -$560.00 thousand

    Cash from investing 1-year change

    -100.57%
    FOLD annual cash flow from investing activities is down -100.57% year-on-year

    Cash from financing

    $5.12M
    FOLD annual cash flow from financing activities is $5.12 million

    Cash from financing 1-year change

    -91.7%
    FOLD annual cash flow from financing activities is down -91.7% year-on-year

    CAPEX

    CAPEX

    $3.55M
    FOLD annual capital expenditures is $3.55 million

    CAPEX 1-year change

    -52.24%
    FOLD annual capital expenditures is down -52.24% year-on-year

    Free Cash Flow

    Free cash flow

    -$37.44M
    FOLD annual free cash flow is -$37.44 million

    Free cash flow 1-year change

    +51.07%
    FOLD annual free cash flow is up +51.07% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    88.36%
    FOLD annual gross profit margin is 88.36%

    Operating margin

    6.45%
    FOLD annual operating profit margin is 6.45%

    Net margin

    -10.62%
    FOLD annual net profit margin is -10.62%

    ROA & ROE

    ROA

    -7.18%
    FOLD annual return on assets is -7.18%

    ROE

    -31.68%
    FOLD annual return on equity is -31.68%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    FOLD price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    FOLD price to earnings ratio is unknown

    PB Ratio

    PB ratio

    11.99
    FOLD price to book ratio is 11.99

    PB ratio Sector rank

    90.66%
    FOLD price to book ratio is higher than 90.66% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.29
    FOLD price to sales ratio is 4.29

    PS ratio Sector rank

    53.84%
    FOLD price to sales ratio is higher than 53.84% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.66B
    FOLD enterprise value is $2.66 billion

    Enterprise value Sector rank

    83.42%
    FOLD enterprise value is higher than 83.42% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    80.82
    FOLD EV/EBITDA is 80.82

    EV/EBITDA Sector rank

    98.03%
    FOLD EV/EBITDA is higher than 98.03% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.39
    FOLD annual current ratio is 3.39

    Quick ratio

    2.60
    FOLD annual quick ratio is 2.60

    Leverage

    Debt to equity

    2.29
    FOLD annual debt to equity ratio is 2.29

    Interest coverage ratio

    -
    FOLD annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    FOLD piotroski f-score is 3

    Altman Z-Score

    -1.09
    FOLD altman z-score is -1.09

    Analyst ratings

    Recent major analysts updates

    Jul 17, 25 Morgan Stanley
    Overweight
    May 2, 25 UBS
    Buy
    May 2, 25 Goldman Sachs
    Neutral
    Feb 20, 25 Wells Fargo
    Overweight
    Feb 20, 25 Needham
    Hold
    Jan 15, 25 Cantor Fitzgerald
    Overweight
    Jan 13, 25 Needham
    Hold
    Dec 13, 24 Morgan Stanley
    Equal-Weight
    Nov 12, 24 JP Morgan
    Overweight
    Nov 7, 24 UBS
    Buy

    Institutional Ownership

    Screeners with FOLD included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Amicus Therapeutics, Inc.?
    • Does Amicus Therapeutics, Inc. pay dividends?
    • What sector is Amicus Therapeutics, Inc. in?
    • What industry is Amicus Therapeutics, Inc. in?
    • What country is Amicus Therapeutics, Inc. based in?
    • When did Amicus Therapeutics, Inc. go public?
    • Is Amicus Therapeutics, Inc. in the S&P 500?
    • Is Amicus Therapeutics, Inc. in the NASDAQ 100?
    • Is Amicus Therapeutics, Inc. in the Dow Jones?
    • When was Amicus Therapeutics, Inc.'s last earnings report?
    • When does Amicus Therapeutics, Inc. report earnings?

    What is the ticker symbol for Amicus Therapeutics, Inc.?

    The ticker symbol for Amicus Therapeutics, Inc. is NASDAQ:FOLD

    Does Amicus Therapeutics, Inc. pay dividends?

    No, Amicus Therapeutics, Inc. does not pay dividends

    What sector is Amicus Therapeutics, Inc. in?

    Amicus Therapeutics, Inc. is in the Healthcare sector

    What industry is Amicus Therapeutics, Inc. in?

    Amicus Therapeutics, Inc. is in the Biotechnology industry

    What country is Amicus Therapeutics, Inc. based in?

    Amicus Therapeutics, Inc. is headquartered in United States

    When did Amicus Therapeutics, Inc. go public?

    Amicus Therapeutics, Inc.'s initial public offering (IPO) was on May 31, 2007

    Is Amicus Therapeutics, Inc. in the S&P 500?

    No, Amicus Therapeutics, Inc. is not included in the S&P 500 index

    Is Amicus Therapeutics, Inc. in the NASDAQ 100?

    No, Amicus Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Amicus Therapeutics, Inc. in the Dow Jones?

    No, Amicus Therapeutics, Inc. is not included in the Dow Jones index

    When was Amicus Therapeutics, Inc.'s last earnings report?

    Amicus Therapeutics, Inc.'s most recent earnings report was on July 31, 2025

    When does Amicus Therapeutics, Inc. report earnings?

    The next expected earnings date for Amicus Therapeutics, Inc. is November 5, 2025
    On this page